Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: CD133 expression is not an independent prognostic factor in stage II and III colorectal cancer but may predict the better outcome in patients with adjuvant therapy

Figure 2

The CD133 IHC expression according to the histologic differentiation of tumors. CD133 is expressed along the glandular luminal side in (A) well-differentiated, (B) moderately differentiated, (C) poorly differentiated tumors, and (D) mucinous adenocarcinomas. Dot-like cytoplasmic staining is observed in poor histologic differentiation (E). CD133 IHC expression is also detected in cancer cells in invasive front (black arrows) (F). (X 100 hematoxylin counterstained).

Back to article page